2011
DOI: 10.2310/6620.2011.11015
|View full text |Cite
|
Sign up to set email alerts
|

Topical and Systemic Therapies for Nickel Allergy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…A pivotal criticism concerns the doses needed to elicit a positive response by challenge test, because in most studies, they exceed up to 10 times the nickel amount deemed present in a normal diet. [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49] Also in our experience, the average challenge dose was higher than in normal diet but just of a light increase (from 0.78 to 1.38 mg above the maximum and the minimum estimated intake by diet), and at least for a certain number of cases, mainly those with stronger and prompter response to the challenge, the dose proved very small (less than or equal to 0.2 mg).…”
Section: Discussionmentioning
confidence: 99%
“…A pivotal criticism concerns the doses needed to elicit a positive response by challenge test, because in most studies, they exceed up to 10 times the nickel amount deemed present in a normal diet. [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49] Also in our experience, the average challenge dose was higher than in normal diet but just of a light increase (from 0.78 to 1.38 mg above the maximum and the minimum estimated intake by diet), and at least for a certain number of cases, mainly those with stronger and prompter response to the challenge, the dose proved very small (less than or equal to 0.2 mg).…”
Section: Discussionmentioning
confidence: 99%
“…A severe form of this allergy is the systemic nickel allergy syndrome, clinically characterized by cutaneous manifestations (contact dermatitis, pompholyx, hand dermatitis dyshidrosis, urticaria) with a chronic course and systemic symptoms (headache, asthenia, itching, and gastrointestinal disorders related to histopathological alterations of gastrointestinal mucosa, borderline with celiac disease) [13]. …”
Section: Introductionmentioning
confidence: 99%
“…Other nickel-specific therapeutic options include disulfiram, acting as a chelating agent for nickel ions, and disodium cromoglycate, on the basis of a decreased nickel intestinal absorption [44].…”
Section: Treatment and Preventionmentioning
confidence: 99%